Global Veterinary Diagnostic Market Size By Type (Immunodiagnostic Tests, Molecular Diagnostics), By Application (Farm Animals, Companion Animals), By Region, And Segment Forecasts, 2023 to 2032

The Global Veterinary Diagnostic Market was valued at USD 4.9 billion in 2023 and is projected to surpass USD 9.3 billion by 2031, expanding at a CAGR of 8.3% during the forecast period from 2023 to 2031. The market is being driven by the rising prevalence of zoonotic diseases, increasing pet ownership, advancements in diagnostic technologies, and the growing demand for early disease detection in animals. The increasing awareness among pet owners regarding animal health and the expansion of veterinary healthcare infrastructure globally have further fueled the demand for accurate and timely diagnostic services.

Drivers:

1. Rising Incidence of Zoonotic and Chronic Diseases:

Diseases transmitted from animals to humans (zoonoses) are increasing, leading to greater investment in animal diagnostics. Furthermore, conditions such as cancer, diabetes, and arthritis in pets are fueling the need for effective diagnostic tools.

2. Technological Advancements in Diagnostics:

The integration of molecular diagnostics, PCR testing, biosensors, and point-of-care diagnostic tools has significantly enhanced the efficiency and precision of veterinary diagnostics.

3. Growing Companion Animal Population:

Increased pet ownership, especially in urban areas, along with the humanization of pets, is boosting demand for regular health check-ups and diagnostic screenings.

Restraints:

1. High Cost of Veterinary Diagnostic Testing:

Advanced diagnostic procedures and equipment come with significant costs, which may deter pet owners in low-income regions or those lacking pet insurance coverage.

2. Limited Access in Developing Countries:

While the market is growing globally, several emerging regions still lack sufficient veterinary infrastructure, skilled professionals, and diagnostic laboratories.

Opportunity:

1. Expansion in Emerging Markets:

Countries in Asia-Pacific and Latin America are witnessing rapid growth in veterinary healthcare infrastructure and increasing awareness about animal welfare, offering lucrative opportunities for market players.

2. Growth of Point-of-Care Diagnostics:

The development and adoption of portable diagnostic tools and at-home test kits are making diagnostics more accessible and affordable, particularly in rural and remote areas.

Market by System Type Insights:

Based on diagnostic type, the Immunodiagnostics segment led the market in 2023, owing to its widespread application in detecting infectious diseases, hormonal disorders, and drug residues in animals. The Molecular Diagnostics segment is expected to witness the fastest growth due to its superior sensitivity and specificity, especially for early disease detection.

Market by End-use Insights:

In terms of end use, Veterinary Hospitals and Clinics accounted for the largest market share in 2023. These settings offer comprehensive animal healthcare and have the infrastructure to perform a wide array of diagnostic tests. However, Reference Laboratories are gaining traction for their ability to handle complex and large-volume tests with greater accuracy and efficiency.

Market by Regional Insights:

North America dominated the veterinary diagnostic market in 2023, supported by high pet ownership rates, advanced veterinary healthcare infrastructure, and substantial R&D investments. Asia-Pacific is projected to register the highest CAGR during the forecast period, driven by increasing livestock production, a rise in animal healthcare spending, and government initiatives supporting veterinary services in countries such as India and China.

Competitive Scenario:

Key players in the global veterinary diagnostic market include IDEXX Laboratories, Zoetis Inc., Thermo Fisher Scientific Inc., Heska Corporation, Virbac, Bio-Rad Laboratories Inc., Randox Laboratories, and Neogen Corporation. These companies are focusing on strategic mergers & acquisitions, technological innovations, and expanding their diagnostic portfolios to strengthen their market presence.

Scope of Work – Global Veterinary Diagnostic Market

Key Market Developments:

2023: IDEXX Laboratories launched a next-gen real-time PCR panel for early detection of tick-borne diseases in canines.

2024: Zoetis Inc. expanded its diagnostic product line with a new handheld analyzer designed for rapid in-clinic diagnostics.

2025: Thermo Fisher Scientific announced a partnership with a leading veterinary chain in Europe to deploy molecular testing platforms across multiple locations.

FAQs:

1. What is the current market size of the Global Veterinary Diagnostic Market?

The market was valued at USD 4.9 billion in 2023.

2. What is the major growth driver of the Global Veterinary Diagnostic Market?

The major growth driver is the rising incidence of zoonotic diseases and advancements in diagnostic technologies.

3. Which is the largest region during the forecast period in the Global Veterinary Diagnostic Market?

North America holds the largest market share.

4. Which segment accounted for the largest market share in the Global Veterinary Diagnostic Market?

The Veterinary Hospitals and Clinics segment accounted for the largest share in 2023.

5. Who are the key market players in the Global Veterinary Diagnostic Market?

Key players include IDEXX Laboratories, Zoetis Inc., Thermo Fisher Scientific Inc., Heska Corporation, and Bio-Rad Laboratories Inc.